Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATRICS-1: MultiStem for Trauma-Induced MOF/SIRS
NCT04533464Phase 2Recruiting
- Sponsor
- Healios
- Start
- Nov 2020
- Primary completion
- Dec 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of invimestrocel in psychological trauma, traumatic hemorrhage, sponsored by Healios. Started Nov 2020; status: recruiting.
02
Drugs
invimestrocel
03
Conditions
psychological traumatraumatic hemorrhage
Beyond the preview
Go deeper on NCT04533464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04533464.